|
US7091181B2
(en)
|
1994-12-12 |
2006-08-15 |
Omeros Corporation |
Method of inhibition of pain and inflammation during surgery comprising administration of soluble TNF receptors
|
|
US6608060B1
(en)
*
|
1996-12-18 |
2003-08-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
CA2306448A1
(en)
|
1997-10-16 |
1999-04-22 |
Board Of Regents, The University Of Texas System |
Models and treatments for cardiac hypertrophy in relation with nf-at3 function
|
|
JP2001526230A
(ja)
|
1997-12-19 |
2001-12-18 |
スミスクライン・ビーチャム・コーポレイション |
ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
|
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
|
WO1999061039A2
(en)
*
|
1998-05-22 |
1999-12-02 |
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel composition for modulating ischemic cell death
|
|
US6858617B2
(en)
|
1998-05-26 |
2005-02-22 |
Smithkline Beecham Corporation |
Substituted imidazole compounds
|
|
AU4429799A
(en)
|
1998-06-12 |
1999-12-30 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
EP1277740A1
(en)
*
|
1998-06-12 |
2003-01-22 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
US6184226B1
(en)
|
1998-08-28 |
2001-02-06 |
Scios Inc. |
Quinazoline derivatives as inhibitors of P-38 α
|
|
AU762245B2
(en)
|
1998-09-18 |
2003-06-19 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of p38
|
|
AR023659A1
(es)
|
1998-09-18 |
2002-09-04 |
Vertex Pharma |
Un compuesto inhibidor de p38, una composicion farmaceutica que lo comprende y el uso de dicha composicion en el tratamiento y prevencion de estados patologicos
|
|
EP1261334A1
(en)
*
|
1998-10-20 |
2002-12-04 |
Omeros Corporation |
Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation
|
|
US6548503B1
(en)
|
1998-11-04 |
2003-04-15 |
Smithkline Beecham Corporation |
Pyridin-4-yl or pyrimidin-4-yl substituted pyrazines
|
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
MXPA01008440A
(es)
|
1999-02-22 |
2002-04-24 |
Boehringer Ingelheim Pharma |
Derivados heterociclicos policiclos como agentes anti-inflamatorios..
|
|
TR200102817T2
(tr)
|
1999-03-12 |
2002-05-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Antiinflamatuar ajanlar olarak faydalı bileşikler
|
|
WO2000055152A1
(en)
|
1999-03-12 |
2000-09-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as anti-inflammatory agents
|
|
JP2000281588A
(ja)
*
|
1999-03-30 |
2000-10-10 |
Sankyo Co Ltd |
ガンの予防又は治療薬及びそのスクリーニング方法
|
|
DE60027431T2
(de)
*
|
1999-07-02 |
2007-07-12 |
Stuart A. Rancho Santa Fe Lipton |
Verwendung von p38 MAPK Inhibitoren in der Behandlung von Augenkrankheiten
|
|
CA2374737C
(en)
|
1999-07-09 |
2008-02-12 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Novel process for synthesis of heteroaryl-substituted urea compounds
|
|
ATE349447T1
(de)
*
|
1999-10-21 |
2007-01-15 |
Hoffmann La Roche |
Alkylamino-substituierte bicyclische heterocyclen als p38 protein kinase inhibitoren
|
|
DE60033307T2
(de)
*
|
1999-10-21 |
2007-07-12 |
F. Hoffmann-La Roche Ag |
Heteroalkylamino-substituierte bicyclische stickstoffheterocyclen als p38-proteinkinase-inhibitoren
|
|
JP2003514900A
(ja)
*
|
1999-11-23 |
2003-04-22 |
スミスクライン・ビーチャム・コーポレイション |
ＣＳＢＰ／ｐ３８キナーゼ阻害剤としての３，４−ジヒドロ−（１Ｈ）−キナゾリン−２−オン化合物
|
|
US6759410B1
(en)
|
1999-11-23 |
2004-07-06 |
Smithline Beecham Corporation |
3,4-dihydro-(1H)-quinazolin-2-ones and their use as CSBP/p38 kinase inhibitors
|
|
DE60023025T2
(de)
|
1999-11-23 |
2006-07-13 |
Smithkline Beecham Corp. |
3,4-dihydro-(1h)chinazolin-2-on-verbindungen als csbp/p39-kinase-inhibitoren
|
|
US6525046B1
(en)
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
|
US7235551B2
(en)
|
2000-03-02 |
2007-06-26 |
Smithkline Beecham Corporation |
1,5-disubstituted-3,4-dihydro-1h-pyrimido[4,5-d]pyrimidin-2-one compounds and their use in treating csbp/p38 kinase mediated diseases
|
|
JP2003528084A
(ja)
*
|
2000-03-22 |
2003-09-24 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
ｐ３８のインヒビター
|
|
MXPA03001256A
(es)
*
|
2000-08-11 |
2004-12-06 |
Vertex Pharma |
Inhibidores de p38.
|
|
PE20020506A1
(es)
*
|
2000-08-22 |
2002-07-09 |
Glaxo Group Ltd |
Derivados de pirazol fusionados como inhibidores de la proteina cinasa
|
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
|
AU2002246855B2
(en)
|
2000-10-23 |
2005-12-22 |
Smithkline Beecham Corporation |
Novel compounds
|
|
US6670357B2
(en)
*
|
2000-11-17 |
2003-12-30 |
Bristol-Myers Squibb Company |
Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
|
|
US6867300B2
(en)
*
|
2000-11-17 |
2005-03-15 |
Bristol-Myers Squibb Company |
Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
|
|
JP2004521892A
(ja)
*
|
2000-12-20 |
2004-07-22 |
メルク エンド カムパニー インコーポレーテッド |
（ハロ−ベンゾカルボニル）複素環縮合フェニル系ｐ３８キナーゼ阻害剤
|
|
SK11322003A3
(en)
*
|
2001-02-12 |
2004-10-05 |
Hoffmann La Roche |
6-Substituted pyrido-pyrimidines
|
|
GB0112348D0
(en)
*
|
2001-05-19 |
2001-07-11 |
Smithkline Beecham Plc |
Compounds
|
|
GB2375771A
(en)
*
|
2001-05-24 |
2002-11-27 |
Univ Leeds |
Decellularisation of tissue implant material
|
|
WO2002100405A1
(en)
|
2001-06-11 |
2002-12-19 |
Vertex Pharmaceuticals Incorporated |
Isoquinoline inhibitors of p38
|
|
US6794265B2
(en)
|
2001-08-02 |
2004-09-21 |
Ultradots, Inc. |
Methods of forming quantum dots of Group IV semiconductor materials
|
|
US20030066998A1
(en)
|
2001-08-02 |
2003-04-10 |
Lee Howard Wing Hoon |
Quantum dots of Group IV semiconductor materials
|
|
US6819845B2
(en)
|
2001-08-02 |
2004-11-16 |
Ultradots, Inc. |
Optical devices with engineered nonlinear nanocomposite materials
|
|
US7005669B1
(en)
|
2001-08-02 |
2006-02-28 |
Ultradots, Inc. |
Quantum dots, nanocomposite materials with quantum dots, devices with quantum dots, and related fabrication methods
|
|
US6710366B1
(en)
|
2001-08-02 |
2004-03-23 |
Ultradots, Inc. |
Nanocomposite materials with engineered properties
|
|
GB0124938D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124941D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124934D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124936D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124933D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124931D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124932D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0124939D0
(en)
*
|
2001-10-17 |
2001-12-05 |
Glaxo Group Ltd |
Chemical compounds
|
|
AU2003212796A1
(en)
*
|
2002-01-11 |
2003-07-30 |
Vertex Pharmaceuticals Incorporated |
Crystal structures of jnk-inhibitor complexes and binding pockets thereof
|
|
JP2005519895A
(ja)
*
|
2002-01-18 |
2005-07-07 |
ファルマシア・コーポレーション |
Ｐ３８阻害剤としての置換ピリダジノン
|
|
CN100369898C
(zh)
*
|
2002-02-12 |
2008-02-20 |
史密丝克莱恩比彻姆公司 |
用作p38抑制剂的烟酰胺衍生物
|
|
EP1480973B1
(en)
|
2002-02-25 |
2008-02-13 |
Boehringer Ingelheim Pharmaceuticals Inc. |
1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
|
|
BR0309259A
(pt)
*
|
2002-04-18 |
2005-02-09 |
Pharmacia Corp |
Terapia combinada para o tratamento de doença de parkinson com inibidores de ciclooxigenase-2 (cox 2)
|
|
KR20040103972A
(ko)
|
2002-04-19 |
2004-12-09 |
스미스클라인 비참 코포레이션 |
신규 화합물
|
|
ATE418546T1
(de)
*
|
2002-04-23 |
2009-01-15 |
Bristol Myers Squibb Co |
Als kinase inhibitoren geeignete arylketonpyrrolotriazin-verbindungen
|
|
US7388009B2
(en)
*
|
2002-04-23 |
2008-06-17 |
Bristol-Myers Squibb Company |
Heteroaryl-substituted pyrrolo-triazine compounds useful as kinase inhibitors
|
|
PL219736B1
(pl)
|
2002-04-23 |
2015-07-31 |
Bristol Myers Squibb Co |
Pochodna pirolotriazynoaniliny, kompozycja farmaceutyczna i jej zastosowanie
|
|
TW200400034A
(en)
*
|
2002-05-20 |
2004-01-01 |
Bristol Myers Squibb Co |
Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
|
|
CA2486183C
(en)
*
|
2002-05-23 |
2012-01-10 |
Cytopia Pty Ltd. |
Protein kinase inhibitors
|
|
AU2003245989A1
(en)
|
2002-07-09 |
2004-01-23 |
Boehringer Ingelheim Pharma Gmbh And Co. Kg |
Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases
|
|
GB0217757D0
(en)
|
2002-07-31 |
2002-09-11 |
Glaxo Group Ltd |
Novel compounds
|
|
US7982008B2
(en)
|
2002-11-27 |
2011-07-19 |
David Bar-Or |
Treatment of diseases and conditions mediated by increased phosphorylation
|
|
GB0308185D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0308201D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
GB0308186D0
(en)
*
|
2003-04-09 |
2003-05-14 |
Smithkline Beecham Corp |
Novel compounds
|
|
EP1617840A4
(en)
*
|
2003-05-01 |
2008-08-20 |
Bristol Myers Squibb Co |
PYRAZOLE AMID COMPOUNDS AS KINASE INHIBITORS
|
|
CA2526285A1
(en)
|
2003-05-15 |
2004-12-23 |
Arqule, Inc. |
Inhibitors of p38 and methods of using the same
|
|
MXPA05013075A
(es)
*
|
2003-06-03 |
2006-03-17 |
Novartis Ag |
Inhibidores de p-38 basados en heterociclo de 5 miembros.
|
|
CN1832928B
(zh)
|
2003-06-26 |
2012-07-04 |
诺瓦提斯公司 |
以5元杂环为基础的p38激酶抑制剂
|
|
WO2005007632A1
(en)
*
|
2003-07-18 |
2005-01-27 |
Pharmacia Corporation |
Substituted pyridazinones as inhibitors of p38
|
|
ATE412642T1
(de)
|
2003-07-25 |
2008-11-15 |
Novartis Ag |
Inhibitoren von p-38-kinase
|
|
GB0318814D0
(en)
*
|
2003-08-11 |
2003-09-10 |
Smithkline Beecham Corp |
Novel compounds
|
|
US7419978B2
(en)
*
|
2003-10-22 |
2008-09-02 |
Bristol-Myers Squibb Company |
Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
|
|
PT1689715E
(pt)
|
2003-12-03 |
2011-05-16 |
Ym Biosciences Australia Pty |
Inibidores da tubulina
|
|
GB0402143D0
(en)
*
|
2004-01-30 |
2004-03-03 |
Smithkline Beecham Corp |
Novel compounds
|
|
WO2006010082A1
(en)
|
2004-07-08 |
2006-01-26 |
Arqule, Inc. |
1,4-disubstituted naphtalenes as inhibitors of p38 map kinase
|
|
US7504521B2
(en)
*
|
2004-08-05 |
2009-03-17 |
Bristol-Myers Squibb Co. |
Methods for the preparation of pyrrolotriazine compounds
|
|
US20060035893A1
(en)
|
2004-08-07 |
2006-02-16 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
|
|
TW200618803A
(en)
|
2004-08-12 |
2006-06-16 |
Bristol Myers Squibb Co |
Process for preparing pyrrolotriazine aniline compounds useful as kinase inhibitors
|
|
WO2006021848A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Ranbaxy Laboratories Limited |
Anti-inflammatory agents
|
|
US20080051416A1
(en)
*
|
2004-10-05 |
2008-02-28 |
Smithkline Beecham Corporation |
Novel Compounds
|
|
CA2584368A1
(en)
|
2004-10-19 |
2006-04-27 |
Arqule, Inc. |
Synthesis of imidazooxazole and imidazothiazole inhibitors of p38 map kinase
|
|
PE20060777A1
(es)
|
2004-12-24 |
2006-10-06 |
Boehringer Ingelheim Int |
Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
|
|
US20060178388A1
(en)
*
|
2005-02-04 |
2006-08-10 |
Wrobleski Stephen T |
Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
|
|
JP2008535822A
(ja)
|
2005-03-25 |
2008-09-04 |
グラクソ グループ リミテッド |
新規化合物
|
|
MY145281A
(en)
|
2005-03-25 |
2012-01-13 |
Glaxo Group Ltd |
Novel compounds
|
|
UY29439A1
(es)
|
2005-03-25 |
2006-10-02 |
Glaxo Group Ltd |
Nuevos compuestos
|
|
AU2006229995A1
(en)
|
2005-03-25 |
2006-10-05 |
Glaxo Group Limited |
Process for preparing pyrido(2,3-d)pyrimidin-7-one and 3,4-dihydropyrimido(4,5-d)pyrimidin-2(1H)-one derivatives
|
|
US20060235020A1
(en)
*
|
2005-04-18 |
2006-10-19 |
Soojin Kim |
Process for preparing salts of 4-[[5-[(cyclopropylamino)carbonyl]-2-methylphenyl]amino]-5-methyl-N-propylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide and novel stable forms produced therein
|
|
GB0512429D0
(en)
*
|
2005-06-17 |
2005-07-27 |
Smithkline Beecham Corp |
Novel compound
|
|
US7473784B2
(en)
*
|
2005-08-01 |
2009-01-06 |
Bristol-Myers Squibb Company |
Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
|
|
US7879875B2
(en)
|
2005-08-12 |
2011-02-01 |
Merk Sharp & Dohme Corp. |
P38 kinase inhibiting agents
|
|
JP5324785B2
(ja)
|
2005-10-28 |
2013-10-23 |
武田薬品工業株式会社 |
複素環アミド化合物及びその用途
|
|
AU2007223342A1
(en)
*
|
2006-03-07 |
2007-09-13 |
Bristol-Myers Squibb Company |
Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
|
|
WO2008057775A2
(en)
|
2006-10-27 |
2008-05-15 |
Bristol-Myers Squibb Company |
Heterocyclic amide compounds useful as kinase inhibitors
|
|
US7943617B2
(en)
|
2006-11-27 |
2011-05-17 |
Bristol-Myers Squibb Company |
Heterobicyclic compounds useful as kinase inhibitors
|
|
CA2681420A1
(en)
*
|
2007-03-20 |
2008-09-25 |
Cadila Pharmaceuticals Limited |
P38 inhibitors
|
|
EP1992344A1
(en)
|
2007-05-18 |
2008-11-19 |
Institut Curie |
P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
|
|
EP2108641A1
(en)
*
|
2008-04-11 |
2009-10-14 |
Laboratorios Almirall, S.A. |
New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
|
|
EP2111861A1
(en)
|
2008-04-21 |
2009-10-28 |
Ranbaxy Laboratories Limited |
Compositions of phosphodiesterase type IV inhibitors
|
|
WO2009155389A1
(en)
*
|
2008-06-20 |
2009-12-23 |
Bristol-Myers Squibb Company |
Triazolopyridine compounds useful as kinase inhibitors
|
|
EP2300466B1
(en)
|
2008-06-20 |
2014-08-06 |
Bristol-Myers Squibb Company |
Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
|
|
WO2010038428A1
(ja)
*
|
2008-09-30 |
2010-04-08 |
武田薬品工業株式会社 |
タキサン系抗がん剤の置き換え薬
|
|
AU2010210426B2
(en)
|
2009-02-06 |
2015-06-11 |
Imago Pharmaceuticals, Inc. |
Inhibitors of Jun N-terminal kinase
|
|
GB0902648D0
(en)
*
|
2009-02-17 |
2009-04-01 |
Argenta Discovery Ltd |
Pharmaceutical compounds and compositions
|
|
GB0908317D0
(en)
*
|
2009-05-14 |
2009-06-24 |
Argenta Discovery Ltd |
Pharmaceutical compounds and compositions
|
|
WO2012031057A1
(en)
|
2010-09-01 |
2012-03-08 |
Bristol-Myers Squibb Company |
Bms- 582949 for the treatment of resistant rheumatic disease
|
|
CA2835707C
(en)
*
|
2011-05-09 |
2019-02-26 |
Eip Pharma, Llc |
Compositions and methods for treating alzheimer's disease
|
|
US20150044178A1
(en)
|
2011-12-28 |
2015-02-12 |
Kyoto Prefectural Public University Corporation |
Normalization of culture of corneal endothelial cells
|
|
CN103772392A
(zh)
*
|
2012-10-23 |
2014-05-07 |
杨子娇 |
一类治疗房角狭窄的化合物及其用途
|
|
US10813920B2
(en)
|
2013-11-14 |
2020-10-27 |
The Doshisha |
Drug for treating corneal endothelium by promoting cell proliferation or inhibiting cell damage
|
|
US9579322B2
(en)
|
2014-07-09 |
2017-02-28 |
Eip Pharma, Llc |
Methods for treating neurologic disorders
|
|
DK3368052T3
(da)
|
2015-10-27 |
2022-03-14 |
Childrens Hospital Med Ct |
Anvendelse af mapk-hæmmere for at nedbringe tabet af hæmatopoietiske stamceller under ex vivo-dyrkning og -genmanipulation
|
|
US20190060286A1
(en)
|
2016-02-29 |
2019-02-28 |
University Of Florida Research Foundation, Incorpo |
Chemotherapeutic Methods
|
|
US11466008B2
(en)
|
2017-09-18 |
2022-10-11 |
Eip Pharma, Llc |
Co-crystals of neflamapimod (VX-745)
|
|
ES2927715T3
(es)
|
2017-10-05 |
2022-11-10 |
Fulcrum Therapeutics Inc |
Inhibidores de la quinasa p38 reducen la expresión de dux4 y de los genes que le siguen para el tratamiento de la FSHD
|
|
CR20200464A
(es)
|
2018-03-08 |
2021-04-14 |
Incyte Corp |
Compuestos diólicos de aminopirazina como inhibidores de pi3k-y
|
|
WO2020010003A1
(en)
|
2018-07-02 |
2020-01-09 |
Incyte Corporation |
AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS
|
|
US20220048915A1
(en)
*
|
2018-11-30 |
2022-02-17 |
Shanghai Pharmaceuticals Holding Co., Ltd. |
Nitrogen-containing Heterocyclic Compound and Composition Thereof, Preparation Method Therefor, and Application Thereof
|